Clean Science and Technology
- Market cap
- ₹ 7,563 Cr.
- P/E
- 33.7x
- P/B
- 5.02x
- 52-week range
- 652 – 1,059.4
- ROE
- 15%
- ROCE
- 21%
- Dividend yield
- 0.5%
- Debt / equity
- 0
- Sector
- Chemicals & Petrochemicals
- Industry
- Specialty Chemicals
- Listed on
- NSE, BSE
About
Clean Science and Technology Limited is an India-based fine and specialty chemical manufacturing company. The Company is engaged in the business of manufacturing organic and inorganic chemicals. Its specialty chemical chemistry is diversified into three segments: performance chemicals, pharma and agro intermediates, and fast-moving consumer goods (FMCG) chemical. Its FMCG chemicals include Anisole, 4-Methoxy Acetophenone, Guaiacol, Tertiary Butyl Hydroquinone, Ortho Methoxy Toluene, L-Ascorbyl Palmitate, and others. Its performance chemicals include Clean Light Stab 770, 4-Hydroxy Tempo, Monomethyl Ether of Hydroquinone, Tertiary Butyl Hydroquinone, Dimethyl Sebacate, and others. Its pharma and agro intermediates include Para Benzoquinone, Para Di-Methoxy Benzene (1,4-DMB), Dicyclohexylcarbodimide, and others. Its subsidiaries include Clean Science Private Limited, Clean Organics Private Limited, Clean Aromatics Private Limited, and Clean Fino-Chem Limited.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Specialty Chemicals: 130 companies →Clean Science and Technology against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)33.7 against a typical 26.3: pricier than most peers (1st = cheapest).81st of 129
- Sales growth+10.3% against a typical +25.9% from a year earlier.93rd of 112
- Profit growth+4.3% against a typical +42.4% from a year earlier.78th of 102
- Share price, 3 months−0.3% against a typical −5.8%.47th of 118
- Size₹ 7,562.6 Cr. market value against a typical ₹ 359.6 Cr. (1st = largest).17th of 126
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
High safety
Rated AA- by CRISIL- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CRISIL | Crisil AA- | Stable | 23 Sep 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 23 Sep 2026 | Reaffirmed | Crisil AA- | — | CRISIL | ₹ 45.45 Cr. | |
| 22 Aug 2025 | Reaffirmed | Crisil AA- | — | CRISIL | ₹ 45.45 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 31 Oct 2026Upcoming | Financial Results | Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, intimation is hereby given that, a meeting of the Board of Directors of the Company will be held on Saturday, 31st October, 2026, to inter alia, consider and approve the Un-audited Standalone and Consolidated Financial Results for the Quarter and Half Year ended 30th September, 2026. |
| 1 Aug 2026 | Financial Results | Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, intimation is hereby given that, a meeting of the Board of Directors of the Company will be held on Saturday, 1st August, 2026, to inter alia, consider and approve the Un-audited Standalone and Consolidated Financial Results for the First Quarter ended 30th June, 2026. |
| 14 May 2026 | Financial Results/Dividend | TIn terms of provisions of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of Clean Science and Technology Limited (the Company ) is scheduled to be held on Thursday, 14th May, 2026, inter alia:a) To consider and approve Standalone and Consolidated Audited Financial Results of the Company for the Quarter and Financial Year ended 31st March, 2026;b) To consider recommending final dividend on the equity shares of the Company for the Financial Year ended 31st March, 2026, if any, subject to the approval of the Shareholders at the ensuing Annual General Meeting. |
| 31 Jan 2026 | Financial Results/Dividend | Prior intimation of the Board Meeting to consider Un-audited Standalone and Consolidated Financial Results for the Quarter and Nine Months ended 31st December, 2025 and Interim Dividend for FY 2025-26. |
| 6 Nov 2025 | Financial Results | Prior Intimation of the Board Meeting to consider Un-audited Standalone and Consolidated Financial Results for the Quarter and Half Year ended 30th September, 2025. |
| 17 Jul 2025 | Financial Results | Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, intimation is hereby given that, a meeting of the Board of Directors of the Company will be held on Thursday, 17th July, 2025, to inter alia, consider and approve the Un-audited Standalone and Consolidated Financial Results for the First Quarter ended 30th June, 2025. |
| 22 May 2025 | Financial Results/Dividend | In terms of provisions of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of Clean Science and Technology Limited (the Company ) is scheduled to be held on Thursday, 22nd May, 2025, inter alia:a) To consider and approve Standalone and Consolidated Audited Financial Results of the Company for the Quarter and Financial Year ended 31st March, 2025;b) To consider recommending final dividend on the equity shares of the Company for the Financial Year ended 31st March, 2025, if any, subject to the approval of shareholders at the ensuing Annual General Meeting. |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 181 | 195 | 228 | 224 | 238 | 241 | 264 | 243 | 245 | 220 | 249 | 268 |
| Expenses | 106 | 108 | 133 | 129 | 148 | 142 | 159 | 143 | 158 | 147 | 153 | 172 |
| Operating Profit | 75 | 87 | 95 | 95 | 90 | 98 | 105 | 100 | 87 | 72 | 96 | 96 |
| OPM % | 41% | 44% | 42% | 42% | 38% | 41% | 40% | 41% | 36% | 33% | 38% | 36% |
| Other Income | 6 | 8 | 14 | 10 | 11 | 5 | 12 | 13 | 7 | 10 | 3 | 22 |
| Interest | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 11 | 11 | 13 | 16 | 18 | 18 | 17 | 19 | 19 | 19 | 21 | 21 |
| Profit before tax | 69 | 83 | 95 | 89 | 83 | 85 | 100 | 95 | 75 | 63 | 78 | 98 |
| Tax % | 25% | 25% | 26% | 26% | 29% | 23% | 26% | 26% | 26% | 27% | 25% | 25% |
| Net Profit | 52 | 63 | 70 | 66 | 59 | 66 | 74 | 70 | 55 | 46 | 58 | 73 |
| EPS in Rs | 4.91 | 5.89 | 6.61 | 6.2 | 5.53 | 6.18 | 6.97 | 6.59 | 5.22 | 4.32 | 5.48 | 6.9 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 13%
- 3 Years
- 1%
- TTM
- 0%
- 10 Years
- —
- 5 Years
- 3%
- 3 Years
- −8%
- TTM
- −13%
- 10 Years
- —
- 5 Years
- −12%
- 3 Years
- −16%
- TTM
- —
- 10 Years
- —
- 5 Years
- 23%
- 3 Years
- 19%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Clean Science and Technology | ₹ 735.35 | ₹ 7,563 Cr. | 33.7x | 5x | 15% | — |
| Asian Paints | ₹ 2,305.00 | ₹ 2,21,095 Cr. | 58.1x | 12.1x | 21.2% | 12.4% |
| Solar Industries India | ₹ 18,320.00 | ₹ 1,65,778 Cr. | 99.6x | 26.6x | 31.4% | 17.7% |
| Pidilite Industries | ₹ 1,514.00 | ₹ 1,54,107 Cr. | 64.8x | 14.7x | 23.8% | 16.9% |
| SRF | ₹ 2,309.00 | ₹ 68,444 Cr. | 44.6x | 6.1x | 13.8% | 11.6% |
| Linde India | ₹ 5,697.00 | ₹ 48,586 Cr. | 110.5x | 14.2x | 13.6% | 21.7% |
Management
- Ashok Ramnarayan Boob
- Executive Vice Chairman of the Board
- Sanjay Parnerkar
- Chief Financial Officer
- Ruchita Vij
- Compliance Officer, Company Secretary
- Siddhartha Ashok Sikchi
- Managing Director, Whole-Time Director
- Krishnakumar Ramnarayan Boob
- Whole-Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.